Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

This study has been completed.
Information provided by (Responsible Party):
Astute Medical, Inc. Identifier:
First received: September 23, 2010
Last updated: February 21, 2013
Last verified: February 2013